QGEN R&D Expenses

Qiagen N.V. Common Shares · R&D Expenses

QGEN logo

QGEN R&D Expenses

Latest reported$194.67M
QGEN TTM R&D Expenses ($1.30M → $194.67M)
High-resolution chart · PNG

QGEN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Qiagen N.V. Common Shares R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
194,673,000
191,994,000
187,516,000
188,886,000
184,591,000
185,944,000
193,494,000
190,855,000
194,336,000
195,126,000
198,511,000
197,264,000
198,198,000
198,201,000
189,859,000
187,253,000
186,653,000
188,907,000
189,964,000
194,196,000
182,025,000
161,693,000
149,073,000
136,716,000
142,464,000
151,473,000
157,448,000
164,127,000
164,312,000
163,118,000
161,852,000
162,129,000
158,528,000
157,682,000
155,990,000
173,557,000
171,330,000
174,663,000
176,592,000
157,791,000
157,157,000
148,612,000
147,181,000
151,391,000
157,284,000
161,618,000
163,626,000
163,498,000
156,377,000
152,107,000
146,071,000
134,490,000
131,158,000
128,140,000
122,477,000
123,080,000
124,718,000
126,605,000
130,635,000
131,860,000
130,194,000
127,109,000
126,039,000
122,560,000
118,327,000
113,854,000
107,900,000
105,390,000
102,716,000
101,606,000
97,332,000
92,126,000
85,923,000
74,773,000
64,935,000
53,103,000
45,358,000
42,903,000
41,560,000
41,297,000
40,049,000
39,235,000
39,100,000
36,240,000
35,004,000
34,840,000
34,159,000
35,389,000
35,286,000
33,651,000
31,789,000
30,358,000
30,130,000
29,251,000
28,177,000
27,433,000
26,248,000
26,543,000
26,769,000
25,760,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.